• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Intern Med . Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Mainten

tetano

Editor, Senior Moderator
Intern Med


. 2024 Sep 27.
doi: 10.2169/internalmedicine.4199-24. Online ahead of print. Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, Japan

Kohei Ishiga[SUP] 1 [/SUP], Hiromichi Wakui[SUP] 1 [/SUP], Kengo Azushima[SUP] 1 [/SUP], Tomohiko Kanaoka[SUP] 1 [/SUP], Daisuke Kanai[SUP] 1 [/SUP], Ryu Kobayashi[SUP] 1 [/SUP], Sho Kinguchi[SUP] 1 [/SUP], Naohito Okami[SUP] 1 [/SUP], Tatsuya Haze[SUP] 2 [/SUP], Takehisa Iwano[SUP] 3 [/SUP], Masashi Sakai[SUP] 4 [/SUP], Kohji Ohki[SUP] 5 [/SUP], Jin Oshikawa[SUP] 6 [/SUP], Toshiharu Kokuho[SUP] 7 [/SUP], Masaaki Hanaoka[SUP] 1 8 [/SUP], Hiroshi Mitsuhashi[SUP] 9 [/SUP], Yukiko Yamada[SUP] 8 [/SUP], Machiko Yabana[SUP] 1 10 [/SUP], Yoshiyuki Toya[SUP] 1 [/SUP], Kouichi Tamura[SUP] 1 [/SUP]



Affiliations
Free article Abstract

Objective Patients undergoing maintenance dialysis are at a higher risk of morbidity and mortality due to severe coronavirus disease 2019 (COVID-19) than the general population. However, longitudinal data regarding this subpopulation of patients are lacking. We therefore examined the prognosis of patients with COVID-19 undergoing maintenance dialysis between 2020 and 2023. In addition, we explored the factors correlated with COVID-19 severity, focusing on the transition thereof throughout the observational period. Methods The primary outcome was the progression to severe or fatal COVID-19. We evaluated the correlation between the primary outcome and baseline demographic and clinical characteristics of patients. Patients undergoing maintenance dialysis who were hospitalized for mild-to-moderate COVID-19 between February 2020 and April 2023 were enrolled at four institutions in Kanagawa, Japan. Results Of the 173 patients, 7 (4.0%) developed severe COVID-19, and 12 (6.9%) died. The severe/death cohort was significantly older, with a higher percentage of unvaccinated patients than the non-severe cohort (58.2% and 25.0%, respectively; p=0.016). Thymus and activation-regulated chemokine levels on admission were lower in the severe/death cohort than in the non-severe cohort, albeit not to a statistically significant degree (148±84 mg/dL and 342±657 pg/mL, respectively; p=0.082). A multivariate logistic regression analysis revealed that the odds ratio for severe morbidity or death was 0.23 (95% confidence interval: 0.07-0.75) for vaccinated patients. Conclusion In patients undergoing maintenance dialysis, the severity rate of COVID-19 is approximately 10%. Vaccination was correlated with a reduced risk of severe COVID-19.

Keywords: COVID-19; Japan; dialysis; severity; vaccination.

 
Back
Top Bottom